Synthetic CBD as a Therapy for COVID-19

• Status: Recruiting
• Trial end date: 2022-01-01

Summary

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

• Phase: Phase 1

Details

• Lead Sponsor: Sheba Medical Center